Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyond
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference118 articles.
1. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009
2. Cutaneous melanoma in the era of molecular profiling;Thompson;Lancet,2009
3. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance;McCubrey;Biochim Biophys Acta,2007
4. Mutations of the BRAF gene in human cancer;Davies;Nature,2002
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The antiproliferative activity of Varronia dardani (Taroda) J.S. Mill. roots against human melanoma cells and the isolation of a new hydroanthraquinone;Phytochemistry Letters;2024-02
2. Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma;Pharmaceutics;2022-01-31
3. Cost-Effectiveness of the Dabrafenib Schedule in Combination With Trametinib Compared With Other Targeted Therapies, Immunotherapy, and Dacarbazine for the Treatment of Unresectable or Metastatic Melanoma With BRAFV600 Mutation in Colombia;Value in Health Regional Issues;2021-12
4. Metabolism and immunity in breast cancer;Frontiers of Medicine;2020-10-19
5. Review of skin cancers terminology, etiology and treatment from ancient Persian medicine view point;Journal of Medicinal Plants;2020-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3